Press Releases and Blog
Blog
ICYMI: Report Finds Big Pharma’s Launch Prices Continue to Rise
ICER Analysis Finds List Prices on Newly Launched Brand Name Products Not Justified by Clinical Value In case you missed it, the Institute for Clinical
PBM Programs Offer Expanded Payments for Independent Pharmacies
Research Finds PBM-Affiliated Pharmacies are a Non-Factor in Rising Drug Costs A strong relationship between pharmacy benefit managers (PBMs) and pharmacies means a better experience
National Survey Finds Employers Widely Satisfied with Transparency, Flexibility, and Savings Provided by PBMs
A survey of nearly 700 employers across the country conducted by NORC at the University of Chicago found that employers are widely satisfied with the transparency, flexibility,
Employers Want Flexibility and Choices in Designing Pharmacy Benefits
Employers Explain How PBMs Help Them Offer Competitive Benefits Pharmacy benefit managers (PBMs) offer employers choice and flexibility to design affordable prescription drug plans that
InsideSources: JC Scott – Exploring Alternatives to the Prescription Drug Rebate System
“PBMs want lower list prices, not bigger rebates.” In a recent op-ed published in InsideSources’ D.C. Journal, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), argues
PBMs Provide Tremendous Value; Without PBMs, It’s Lost
PBMs are the only check against Big Pharma’s pricing power. But PBMs do far more than negotiate rebates. PBMs also improve patient health outcomes, encourage
Press Releases
Brendan Buck to Serve as Chief Communications Officer
(Washington, D.C.) — Marking a new era for the organization, today the board of directors of the Pharmaceutical Care Management Association (PCMA) announced that David Marin has been named its new President and CEO, following a thorough search. Marin brings three decades of public policy and coalition-building experience to PCMA and joins the organization from […]
Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced that Sean Williams is joining the organization as Senior Vice President of State Affairs. He will officially begin his role in January 2026. “I’m pleased to welcome Sean Williams to the PCMA team,” said Chief Government Affairs Officer and Interim CEO Lucia Lebens. “At PCMA, […]
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement following the Trump Administration’s announcement on lowering prices on GLP-1 products. “America’s pharmacy benefit managers (PBMs) applaud the Trump Administration for continuing to hold Big Pharma accountable for the egregious prices they set on brand-name drugs in the United States, especially for […]
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement following the Trump Administration’s biosimilar announcement. “America’s pharmacy benefit managers (PBMs) commend the Trump Administration’s dedication to lowering prescription drug costs. Today’s announcement to remove the unnecessary step of providing studies for biosimilar interchangeability is a watershed moment for making biosimilars more […]
(Washington, D.C.) — After more than seven years leading the Pharmaceutical Care Management Association (PCMA) and in the last year of his contract with the organization, PCMA President and CEO Juan Carlos “JC” Scott today announced his decision to step down before the end of the year. “JC has led PCMA during a critical period […]
(Sacramento, CA) — The Pharmaceutical Care Management Association (PCMA) released the following statement following the signing of SB 41 by Governor Gavin Newsom. “It is a failure of the Newsom administration to fall for Big Pharma’s ploy to blame their high list prices on others and to undermine the very mechanisms that actually lower prescription […]
ICYMI: Report Finds Big Pharma’s Launch Prices Continue to Rise
ICER Analysis Finds List Prices on Newly Launched Brand Name Products Not Justified by Clinical Value In case you missed it, the Institute for Clinical
PBM Programs Offer Expanded Payments for Independent Pharmacies
Research Finds PBM-Affiliated Pharmacies are a Non-Factor in Rising Drug Costs A strong relationship between pharmacy benefit managers (PBMs) and pharmacies means a better experience
National Survey Finds Employers Widely Satisfied with Transparency, Flexibility, and Savings Provided by PBMs
A survey of nearly 700 employers across the country conducted by NORC at the University of Chicago found that employers are widely satisfied with the transparency, flexibility,
Employers Want Flexibility and Choices in Designing Pharmacy Benefits
Employers Explain How PBMs Help Them Offer Competitive Benefits Pharmacy benefit managers (PBMs) offer employers choice and flexibility to design affordable prescription drug plans that
InsideSources: JC Scott – Exploring Alternatives to the Prescription Drug Rebate System
“PBMs want lower list prices, not bigger rebates.” In a recent op-ed published in InsideSources’ D.C. Journal, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), argues
PBMs Provide Tremendous Value; Without PBMs, It’s Lost
PBMs are the only check against Big Pharma’s pricing power. But PBMs do far more than negotiate rebates. PBMs also improve patient health outcomes, encourage
Welcome Back, Congress: Here’s What To Know About PBMs
Welcome back to Washington. As Congress returns, it’s a good time to brush up on the positive impact pharmacy benefit managers (PBMs) are having in
PBMs Support Legislation to Promote Competition and Make Drugs More Affordable
PBMs support lower list prices for all prescription drugs for every patient and have launched innovative programs to lower costs, including breaking down barriers to biosimilar use and offering cost-sharing
Rx Research Corner: Drug Companies Continue to Set High Prescription Drug Launch Prices
High list prices on brand prescription drugs continue to be a challenge for payers and patients. PBMs applauded when certain drug companies brought down the
New JAMA Research Finds Healthy Churn in the Pharmacy Market
Academic Analysis Finds Independent Pharmacies Open as Frequently As They Close New research in JAMA Health Forum from University of Utah Professor Joey Mattingly, Maitreyi Sahu at University
